SGRY
Surgery Partners Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Surgery Partners Inc is a healthcare services company providing outpatient surgical services and integrated healthcare solutions across the United States.
Surgery Partners Inc
SGRY
Surgery Partners Inc is a healthcare services company providing outpatient surgical services and integrated healthcare solutions across the United States.
Price history of Surgery Partners Inc
Price history of Surgery Partners Inc
Performance & Momentum
Surgery Partners Shares Gain Ahead of Q3 Results
Surgery Partners (NASDAQ: SGRY) shares have risen about 9% over the past month despite a challenging year overall for the company. This recent uptick has drawn investor interest ahead of the Q3 2025 earnings release scheduled for Monday before market open. However, the market remains cautious as annual performance is still under pressure, and upcoming results will be closely watched to assess Surgery Partners' ability to sustain a turnaround.
Strategic Analysis
Surgery Partners Inc • 2026
Surgery Partners operates a network of ambulatory surgical centers and specialty care facilities, a positioning that aligns with the structural pressure to shift certain procedures out of traditional hospital settings. The group stands out for exposure to a healthcare segment that is generally more cost-efficient, with a model centered on scheduled surgery and specialized medical services.
- Defensive positioning in outpatient care, supported by the healthcare system's push for greater efficiency in the US
- Recurring and specialized medical services model, less dependent on a single type of procedure
- Presence in a large US market, favorable to the consolidation of surgical centers
- Markedly deteriorating stock trend across multiple time horizons, signaling a loss of investor confidence
- Exposure to pressure on reimbursement rates, operating costs, and site profitability
- Execution may be more demanding in an environment where organic growth must offset weak market sentiment
Momentum is weak and market dynamics remain clearly negative, with an underlying trend suggesting persistent investor skepticism rather than a mere temporary setback. In the absence of recent catalysts capable of reigniting interest in the name, the stock appears more like a turnaround story than a confirmed growth case, warranting a cautious and selective approach.
Similar stocks to Surgery Partners Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
